Sara Busacca
Lancaster Road
Leicester, ENG LE19HN, United Kingdom
Leicester, ENG LE19HN, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.
Journal: EClinicalMedicine
Published: January 07, 2022
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Journal: Nature communications
Published: June 08, 2021
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.
Journal: British journal of cancer
Published: April 18, 2021
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.
Journal: Scientific reports
Published: September 21, 2020
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Journal: Nature communications
Published: September 18, 2020
BRCA1/MAD2L1 Deficiency Disrupts the Spindle Assembly Checkpoint to Confer Vinorelbine Resistance in Mesothelioma.
Journal: Molecular cancer therapeutics
Published: May 04, 2020
Ganetespib in Combination with Pemetrexed-Platinum Chemotherapy in Patients with Pleural Mesothelioma (MESO-02): A Phase Ib Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 08, 2020
Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells.
Journal: eLife
Published: July 07, 2017
Resistance to HSP90 inhibition involving loss of MCL1 addiction.
Journal: Oncogene
Published: October 29, 2014
Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 08, 2014
Last Updated: 09/26/2026